Measles IgG antibody index correlates with T2 lesion load on MRI in patients with early multiple sclerosis

PLoS ONE

Volumn 7, Issue 1, 2012, Pages

  Rosche, Berit ^a   Laurent, Sarah ^a   Conradi, Silja ^a   Hofmann, Jörg ^a   Ruprecht, Klemens ^a   Harms, Lutz ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; MEASLES ANTIBODY; IMMUNOGLOBULIN G; VIRUS ANTIBODY;

ADULT; ARTICLE; BRAIN DAMAGE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DISEASE ACTIVITY; FEMALE; HUMAN; LUMBAR PUNCTURE; MAJOR CLINICAL STUDY; MALE; MEASLES VIRUS; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; RUBELLA VIRUS; VARICELLA ZOSTER VIRUS; ADOLESCENT; IMMUNOLOGY; MEASLES; METHODOLOGY; MIDDLE AGED; PATHOLOGY; VIROLOGY;

HUMAN HERPESVIRUS 3; MEASLES VIRUS; RUBELLA VIRUS;

ADOLESCENT; ADULT; ANTIBODIES, VIRAL; FEMALE; HUMANS; IMMUNOGLOBULIN G; MAGNETIC RESONANCE IMAGING; MALE; MEASLES; MEASLES VIRUS; MIDDLE AGED; MULTIPLE SCLEROSIS; YOUNG ADULT;

EID: 84855986628     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0028094     Document Type: Article

References (16)

1. Barkhof F, Filippi M, Miller DH, Scheltens P, Campi A, et al. (1997) Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain 120: 2059-2069.
2. Swanton JK, Rovira A, Tintore M, Altmann DR, Barkhof F, et al. (2007) MR1 criteria for multiple sclerosis in patients presenting with clinically isolated syndromes: a multicentre retrospective study. Lancet Neurology 6: 677-686.
3. Felgenhauer K, Reiber H, (1992) The Diagnostic-Significance of Antibody Specificity Indexes in Multiple-Sclerosis and Herpes-Virus InducedDiseases of the Nervous-System. Clinical Investigator 70: 28-37.
4. Jarius S, Eichhorn P, Jacobi C, Wildemann B, Wick M, et al. (2009) The intrathecal, polyspecific antiviral immune response: Specific for MS or ageneral marker of CNS autoimmunity? Journal of the NeurologicalSciences 280: 98-100.
5. Cepok S, Jacobsen M, Schock S, Omer B, Jaekel S, et al. (2001) Patterns of cerebrospinal fluid pathology correlate with disease progression inmultiple sclerosis. Brain 124: 2169-2176.
6. Nociti V, Frisullo G, Marti A, Luigetti M, Iorio R, et al. (2010) Epstein-Barr virusantibodies in serum and cerebrospinal fluid from Multiple sclerosis,Chronic Inflammatory Demyelinating Polyradiculoneuropathy andAmyotrophic Lateral Sclerosis. Journal of Neuroimmunology 225: 149-152.
7. Villar LM, Masjuan J, Gonzalez-Porque P, Plaza J, Sadaba MC, et al. (2002) Intrathecal IgM synthesis in neurologic diseases: Relationship withdisability in MS. Neurology 58: 824-826.
8. Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, et al. (2011) Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 69: 292-302.
9. Rieckmann P, Toyka KV, (2002) Immunomodulatory staged therapy of multiple sclerosis.New aspects and practical applications. Nervenarzt 73: 556-63.
10. Reiber H, (1998) The intrathecal, polyspecific and oligoclonal immune response in multiple sclerosis. Mult Scler 4: 111-7.
11. Brettschneider J, Tumani H, Kiechle U, Muche R, Richards G, et al. (2009) IgG Antibodies against Measles, Rubella, and Varicella Zoster Virus Predict Conversion to Multiple Sclerosis in Clinically Isolated Syndrome. PlosOne 4.
12. Derfuss T, Gurkov R, Bergh FT, Goebels N, Hartmann M, et al. (2001) Intrathecal antibody production against Chlamydia pneumoniae in multiple sclerosis is part of a polyspecific immune response. Brain 124: 1325-1335.
13. Jacobi C, Lange P, Reiber H, (2007) Quantitation of intrathecal antibodies incerebrospinal fluid of subacute sclerosing panencephalitis, herpes simplex encephalitis and multiple sclerosis: Discrimination between microorganism-driven and polyspecific immune response. Journal of Neuroimmunology 187: 139-146.
14. Reiber H, Peter JB, (2001) Cerebrospinal fluid analysis: disease-related data patterns and evaluation programs. Journal of the Neurological Sciences 184: 101-122.
15. Walsh MJ, Tourtellotte WW, (1986) Temporal Invariance and Clonal Uniformity of Brain and Cerebrospinal Igg, Iga, and Igm in Multiple-Sclerosis. Journal of Experimental Medicine 163: 41-53.
16. Comi G, Filippi M, Barkhof F, Durelli L, Edan G, et al. (2001) Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study. Lancet 357: 1576-1582.